Amgen (AMGN): No Conclusion on Sensipar's Role in Death, Still Working with FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. ADI
5. SPY
6. MRK
7. MRNA
8. TJX
9. DE
10. LOW

Go back to Amgen (AMGN): No Conclusion on Sensipar's Role in Death, Still Working with FDA
Amgen Inc (NASDAQ: AMGN) Delayed: 433.28 -9.08 (2.05%)
Previous Close $442.36    52 Week High $176.85 
Open $435.78    52 Week Low $133.64 
Day High $438.29    P/E 65.25 
Day Low $431.46    EPS $6.64 
Volume 498,972